Defective fibrinolysis in Behçet's syndrome: significance and possible mechanisms.
Open Access
- 1 July 1989
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 48 (7) , 590-593
- https://doi.org/10.1136/ard.48.7.590
Abstract
Reduced fibrinolytic activity has frequently been reported in Behcet's syndrome, but both the underlying mechanism and its relation to the development of thrombosis are unclear. The fibrinolytic activity was studied in seven patients with Behçet's syndrome and 12 patients with idiopathic oral ulceration. The patients with Behçet's disease had significantly reduced resting tissue plasminogen activator(t-PA) both by euglobulin fibrin plate lysis and enzyme linked immunosorbent assay (ELISA), but the tissue plasminogen activator inhibitor(t-PAI) was not significantly different from the control value. After stimulation by venous occlusion the euglobulin fibrin plate lysis results showed three good responders and four poor responders, but neither t-PA antigen nor t-PAI concentrations showed any clear difference between the two groups. Interestingly, three out of the four patients with a history of thrombosis were good responders. The group with oral ulceration showed no significant difference from the controls for any of these measurements. These findings suggest that the reduced resting fibrinolytic activity is usually due to decreased production of t-PA, but that the defective response to stimulation may be multifactorial in origin. The fibrinolytic abnormalities appear unrelated to the development of thrombosis.This publication has 9 references indexed in Scilit:
- ABNORMAL FIBRINOLYTIC ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND POSSIBLE MECHANISMSRheumatology, 1988
- The effect of stanozolol on various types of defective fibrinolysisFibrinolysis, 1987
- Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.BMJ, 1985
- Evidence for an endothelial cell dysfunction in association with Behçet's diseaseThrombosis Research, 1984
- Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditionsThrombosis Research, 1984
- Factual or Artificial Inhibition of Fibrinolysis and the Occurrence of Venous Thrombosis in 3 Cases of Behçet's DiseaseScandinavian Journal of Haematology, 1981
- Inhibition of the Fibrinolytic System in Behçet’s Disease?Pathophysiology of Haemostasis and Thrombosis, 1977
- Behçet's syndrome with arthritis.Annals of the Rheumatic Diseases, 1969